Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | NMT1 | P30419 | 6/20 | 0.40 |
| ▸ | NMT2 | O60551 | 5/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
| ▸ | TLR2 | O60603 | 1/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL2577660 | 0.89 | KMT2A (0.33) | SLC6A5NMT1NMT2FOLH1NOD1 | |
| SCHEMBL2520684 | 0.86 | SLC6A5 (0.56) | SLC6A5NMT1NMT2FOLH1RNPEP | |
| SCHEMBL2581261 | 0.86 | SLC6A5 (0.56) | SLC6A5NMT1NMT2FOLH1RNPEP | |
| Zinc Ion SCHEMBL2574083 | 0.86 | NOD1 (0.44) | SLC6A5NOD1 | |
| SCHEMBL2580308 | 0.85 | SLC6A5 (0.55) | SLC6A5NMT1NMT2FOLH1RNPEP | |
| Zinc Ion SCHEMBL2577508 | 0.84 | FOLH1 (0.36) | FOLH1NOD1 | |
| Zinc Ion SCHEMBL2585203 | 0.84 | NMT1 (0.34) | NMT1NMT2NOD1 | |
| Zinc Ion SCHEMBL3338508 | 0.84 | EPHX2 (0.43) | NOD1 | |
| Zinc Ion SCHEMBL2580359 | 0.83 | EPHX2 (0.42) | NOD1 | |
| Zinc Ion SCHEMBL2574899 | 0.82 | FNTA (0.46) | RNPEPNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8048911-B2 | Melanin eliminator preparation | OGA Research, Inc. (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20090093541-A1 | MELANIN ELIMINATOR PREPARATION | OGA RESEARCH, INC (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20060122100-A1 | Melanin extinguisher | OGA RESEARCH, INCORPORATED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1547590-A1 | MELANIN EXTINGUISHER | Oga Research, Incorporated (JP) | 2005-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122100-A1 | Melanin extinguisher | TYR, MC1R, MITF | SLC6A5 2176/4885NMT1 1190/4885NMT2 1612/4885 |
| US-20090093541-A1 | MELANIN ELIMINATOR PREPARATION | TYR, MC1R, MCHR1 | SLC6A5 1510/4885NMT1 583/4885NMT2 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.